Results 1 to 10 of about 11,123,914 (335)
The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options. [PDF]
Journal of Ocular Pharmacology and Therapeutics, 2020 Homeostasis of the lacrimal functional unit is needed to ensure a well-regulated ocular immune response comprising innate and adaptive phases. When the ocular immune system is excessively stimulated and/or immunoregulatory mechanisms are disrupted, the ...
Lin, Meng C +4 more
core +3 more sources
A Review on Dry Eye Disease Treatment: Recent Progress, Diagnostics, and Future Perspectives
Pharmaceutics, 2023 Dry eye disease is a multifactorial disorder of the eye and tear film with potential damage to the ocular surface. Various treatment approaches for this disorder aim to alleviate disease symptoms and restore the normal ophthalmic environment.
Himangsu Mondal +3 more
semanticscholar +1 more source
miR-204–containing exosomes ameliorate GVHD-associated dry eye disease
Science Advances, 2022 MSC-exo eye drops alleviate GVHD-associated dry eye disease by shifting M1 macrophages to M2 via miR-204.
Tian Zhou +13 more
semanticscholar +1 more source
Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease
International Journal of Molecular Sciences, 2022 Dry eye disease (DED) is the most common ocular surface disease, characterized by insufficient production and/or instability of the tear film. Tear substitutes are usually the first line of treatment for patients with DED.
M. Labetoulle +6 more
semanticscholar +1 more source
Hyaluronic acid in the treatment of dry eye disease
Acta ophthalmologica, 2022 Dry eye disease (DED) is a highly prevalent and debilitating condition affecting several hundred million people worldwide. Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan commonly used in the treatment of DED.
Leif Hynnekleiv +7 more
semanticscholar +1 more source
Annals medicus, 2022 Dry eye disease (DED) is a multifactorial disorder characterized by loss of tear film homeostasis with an estimated worldwide prevalence of 5% to 50%.
J. Sheppard +2 more
semanticscholar +1 more source
Annual Review of Medicine, 1952 The purpose of this review of ophthalmic articles appearing in the litera ture between September 1950 and September 1951 is to present the salient features of original contributions which either facilitate the understanding of disease processes or bear on medical therapy. Overlapping efforts along similar lines are generally not noted.
Arthur H. Keeney, Irving H. Leopold
openaire +3 more sources
The global prevalence of dry eye disease: A Bayesian view
Ophthalmic & physiological optics, 2021 To provide estimates for the prevalence of dry eye disease globally and in sub‐groups defined by: diagnostic criterion, sex, geographic location and age, using a Bayesian approach.
E. Papas
semanticscholar +1 more source
Teprotumumab for the treatment of chronic thyroid eye disease
Eye, 2021 Teprotumumab, a novel IGF-1R antibody was recently shown to significantly reduce the signs of active Thyroid eye disease (TED). The current study reviews its efficacy in chronic TED.
Shoaib Ugradar +8 more
semanticscholar +1 more source
Management Strategies for Evaporative Dry Eye Disease and Future Perspective
Current Eye Research, 2022 Dry eye disease (DED) is a common disorder that remains challenging from a clinical perspective. Unstable or deficient tear film is a major factor contributing to DED and the inability to resolve the loss of tear film homeostasis that accompanies DED can
M. Rolando, J. Merayo-Lloves
semanticscholar +1 more source